Related Experiment Videos

Inhibition of RNA synthesis by acetyl salicylate and actinomycin D during early development in the mouse

Pediatric Research
|August 1, 1975
PubMed

Insights

Acetyl salicylate and actinomycin D both inhibit RNA synthesis in mouse oocytes. Salicylate

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Toxicology

Background:

  • RNA synthesis is crucial for oocyte development.
  • Understanding drug effects on early oogenesis is important for reproductive health.

Purpose of the Study:

  • To compare the effects of acetyl salicylate and actinomycin D on mouse oocyte RNA synthesis.
  • To investigate the reversibility and in vivo consequences of these drug exposures.

Main Methods:

  • In vitro and in vivo experiments using mouse oocytes.
  • Measurement of RNA synthesis via [3H]uridine incorporation and autoradiography.
  • Assessment of fetal and progeny development after in utero exposure.

Main Results:

  • Both acetyl salicylate and actinomycin D inhibit RNA synthesis in oocytes.
  • Actinomycin D caused a greater inhibition of RNA synthesis than acetyl salicylate.
  • Salicylate's effects were potentially reversible; actinomycin D's were not.
  • In utero exposure led to sterility and/or abnormal development in offspring.

Conclusions:

  • RNA synthesis during early oogenesis is vital for oocyte development and reproductive success.
  • Inhibition of RNA synthesis by drugs like salicylate may cause malformations and sterility.
  • These findings highlight potential risks of drug exposure during fetal development.

Related Concept Videos